News

Net Loss of Lasa Supergenerics reported to Rs 4.16 crore in the quarter ended March 2026 as against net loss of Rs 14.29 crore during the previous quarter ended March 2025. Sales reported to Rs -0.13 crore in the quarter ended March 2026 as against Rs 39.14 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 34.09 crore in the year ended March 2026 as against net loss of Rs 14.76 crore during the previous year ended March 2025. Sales declined 82.35% to Rs 25.14 crore in the year ended March 2026 as against Rs 142.45 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales-0.1339.14 PL 25.14142.45 -82 OPM %1623.088.71 --29.284.39 - PBDT-2.205.69 PL -7.558.58 PL PBT-3.511.79 PL -13.57-3.72 -265 NP-4.16-14.29 71 -34.09-14.76 -131 Powered by Capital Market - Live News

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net loss of Lasa Supergenerics reported to Rs 2.55 crore in the quarter ended December 2025 as against net profit of Rs 5.49 crore during the previous quarter ended December 2024. Sales declined 93.35% to Rs 2.20 crore in the quarter ended December 2025 as against Rs 33.08 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2.2033.08 -93 OPM %-34.090.82 - PBDT-0.840.46 PL PBT-2.41-2.34 -3 NP-2.555.49 PL Powered by Capital Market - Live News

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News